Immunohistochemical study of 100 pancreatic tumors in 28 patients with multiple endocrine neoplasia, type I

American Journal of Surgical Pathology

Volumn 20, Issue 11, 1996, Pages 1378-1384

  Le Bodic, Marie Françoise ^a,j   Heymann, Marie Françoise ^a   Lecomte, Martine ^b   Berger, Nicole ^c   Berger, Françoise ^c   Louvel, Albert ^d   De Micco, Catherine ^e   Patey, Martine ^f   De Mascarel, Antoine ^g   Burtin, Florence ^h   Saint Andre, Jean Paul ⁱ  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d Institut Cochin   (France)

^e CNRS Marseille Universities   (France)

^f University Hospital of Reims   (France)

^g BORDEAUX UNIVERSITY HOSPITAL   (France)

^h RENNES UNIVERSITY HOSPITAL   (France)

ⁱ ANGERS UNIVERSITY HOSPITAL   (France)

^j CHU de Nantes   (France)

more..

Author keywords

Immunohistochemistry; Multiple endocrine neoplasia, type I; Pancreatic endocrine tumors

Indexed keywords

CALCITONIN; CHORIONIC GONADOTROPIN ALPHA SUBUNIT; CHROMOGRANIN A; CORTICOTROPIN; GASTRIN; GLUCAGON; GONADORELIN; INSULIN; NEURON SPECIFIC ENOLASE; PANCREAS POLYPEPTIDE; SEROTONIN; SOMATOSTATIN; SYNAPTOPHYSIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLUCAGONOMA; HORMONE RELEASE; HUMAN; HUMAN TISSUE; HYPOGLYCEMIA; IMMUNOHISTOCHEMISTRY; INSULINOMA; MALE; MULTIPLE ENDOCRINE NEOPLASIA; PANCREAS RESECTION; PANCREAS TUMOR; TUMOR CLASSIFICATION; ZOLLINGER ELLISON SYNDROME;

ADOLESCENT; ADULT; ANTIBODIES, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; GLUCAGONOMA; HUMANS; HYPOGLYCEMIA; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PANCREATIC NEOPLASMS; SYNDROME; ZOLLINGER-ELLISON SYNDROME;

EID: 10344257997     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199611000-00009     Document Type: Article

References (30)

1. Asa SL, Singer W, Kovacs K, et al. Pancreatic endocrine tumourproducing growth hormone-releasing hormone associated with multiple endocrine neoplastic type I syndrome. Acta Endocrinol (Copenh) 1987;115:331-7.
2. Berger G, Trouillas J, Bloch B, et al. Multihormonal carcinoid tumor of the pancreas: secreting growth hormone-releasing factor as a cause of acromegaly. Cancer 1984;54:2097-108.
3. Calender A, Schuffenecker I, Lenoir GM. The genetics of multiple endocrine neoplasia (MEN). Horm Res 1992;38:16-23.
4. Cougard P, Proye C. Registre national des néoplasies endocriniennes multiples de type I: résultats préliminaires de l'enquête de l'Association française de chirurgie endocrinienne. Rev Franç Endocrinol Clin 1991;62:219-27.
5. Donow C, Pipeleers-Marichal M, Schröder S, Stamm B, Heitz PU, Klöppel G. Surgical pathology of gastrinoma. Site. size, multicentricity, association with multiple endocrine neoplasia type I, and malignancy. Cancer 1991;68:1329-34.
6. Friesen SR, Tomita T, Kimmel JR. Pancreatic polypeptide update: its role in detection of the trait for multiple endocrine adenopathy syndrome, type I, and pancreatic polypeptide-secreting tumors. Surgery 1983;94:1028-37.
7. Giraud-Pinloche S, Chabrier G, Lenoir GM, Calender A. Dépistage génétique des néoplasies endocriennes multiple de type I (syndrome de Wermer). Presse Med 1993;22:637.
8. Guesdon JL, Ternynck T, Auramea S. The use of avidin-biotin interactions in immunoenzymatic techniques. Histochem Cytochem 1970;27:1131-9.
9. Heitz P, Klöppel G, Polak JM, Staub JJ. Ectopic hormone production by endocrine tumours: localisation of hormones at the cellular level by immunochemistry. Cancer 1981;48:2029-37.
10. Heitz PU, Kasper M, Polak JM, Klöppel G. Pancreatic endocrine tumors: immunocytochemical analysis of 125 tumors. Hum Pathol 1982;13:263-71.
11. Heitz PU. Pancreatic endocrine tumours in pancreatic pathology. In: Klöppel G, Heitz PU, eds. New York: Churchill Livingstone, 1984;13:206-32.
12. Hsu SM, Raine L, Fanger H. Use of avidin-biotin peroxidase complex (ABC) in immuno-peroxidase techniques a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80.
13. Klöppel G, Willemers S, Stamm B, Häcki WH, Heitz PU. Pancreatic lesions and hormonal profile of pancreatic tumors in multiple endocrine neoplasia type 1: an immunocytochemical study of nine patients. Cancer 1986;57:1824-32.
14. Klöppel G, Höfler H, Heitz PU. In: Polak JM Diagnostic histopathology of endocrine tumours, Edinburgh: Churchill Livingstone, 1993;91-121.
15. Klöppel G, Schröder S, Heitz PU. In: Mignon M, Jensen RT, eds. Endocrine tumors of the pancreas. Frontiers Gastrointest Res. Basel: Karger. 1995;23:99-120.
16. Larsson C, Skogseid B, Öberg K, Nakamura Y, Nordenskjöld M. Multiple endocrine neoplasia type I gene maps to chromosome 11 and is lost in insulinoma. Nature 1988;332:85-7.
17. Long RG, Bryant MG, Mitchell SJ, Adrian TE, Polak JM, Bloom SR. Clinicopathological study of pancreatic and ganglioneuroblastoma tumours secreting vasoactive intestinal polypeptide (VIPomas). Br Med J 1981;282:1767-71.
18. Moldawer MP, Nordi GL, Raker W. Concomitance of multiple adenomas of the parathyroids and pancreatic islets with tumour of the pituitary: a syndrome with familial incidence. Am J Med Sci 1954;228:190.
19. Öberg L, Wälinder O, Boström H, Lundqvist G, Wide L. Peptide hormone markers in screening for endocrine tumors in multiple endocrine adnomatosis type I. Am J Med 1982:73:619-30.
20. Ooi A, Kamey AT, Tsumumaya M, et al. Pancreatic endocrine tumors associated with WDHA, syndrome: an immunohistochemical and electronmicroscopic study. Virchows Arch A 1985; 405:311-23.
21. Peurifoy JT, Gomez LG, Thompson JC. Separate pancreatic gastrin cell and beta-cell adenomas: report of a patient with multiple endocrine adenomatosis type I. Arch Surg 1979;114:956-8.
22. Pipeleers-Marichal M, Donow C, Heitz PU, Klöppel G. Pathologic aspects of gastrinomas in patients with Zollinger-Ellison syndrome with and without multiple endocrine neoplasia type I. Word J Surg 1993;17:481-8.
23. Ruszniewski P, Podevin P, Cadiot G, et al. Clinical, anatomical and evolutive features of patients with the Zollinger-Ellison syndrome combined with type I multiple endocrine neoplasia. Pancreas 1993;8:295-304.
24. Samaan NA, Ouais S, Ordonez NG, Chocks UA, Sellin RV, Hickey RC. Multiple endocrine syndrome type I: clinical, laboratory findings and managements in five families. Cancer 1989;64: 741-52.
25. Sano T, Asa SI, Kovacs K. Growth hormone-releasing hormoneproducing tumours: clinical, biochemical and morphological manifestations. Endocr Rev 1988;9:357-73.
26. Sheppard BC, Norton JA, Doppman JL, Maton PN, Gardner JD, Jensen RT. Management of islet cell tumors in patients with multiple endocrine neoplasia: a prospective study. Surgery 1989;106: 1108.
27. Stacpoole PW, Jaspan J, Kasselberg AG, et al. A familial glucagonoma syndrome: genetic, clinical and biochemical features. Am J Med 1981;70:1017-26.
28. Thompson NW, Lloyd RV, Nishiyama RH, et al. MEN I pancreas: a histological and immunohistochemical study. World J Surg 1984; 8:561-74.
29. Warner TFCS, Block M, Hafez R, Mack E, Lloyd RV, Bloom SR. Glucagonomas, ultrastructure and immunocytochemistry. Cancer 1983;51:1091-6.
30. Wermer P. Multiple endocrine adenomatosis: multiple hormoneproducing tumours, a familial syndrome. Clin Gastroenterol 1974; 3:671-84.